Articles by Daniel Marsh
Transocean Shares Near $5.30 Amid Focus on Q2 Cash Flow and Noble's Outlook
Transocean shares hover near $5.30 as investors await Q2 earnings, with a focus on cash flow conversion amid strong offshore dayrates.
Apple Reclaims World's Most Valuable Company Title, Market Rewards Capital Discipline
Apple surpasses Nvidia in market cap as investors reward its capital-light strategy and strong cash generation, despite Nvidia's faster revenue growth.
Nu Holdings Shares Rise 3% in Premarket Despite Buyback Impact
Nu Holdings shares rose 3% in premarket trading, supported by strong Q1 earnings and a new banking license in Brazil, though higher credit-loss allowances and a rising stock price are limiting buyback impact.
C3is Inc. Shares Recover After Sharp Decline Amid Dilutive Financing
C3is Inc. shares surged over 100% in premarket trading after an 80.3% decline, but the company's recent financing deal values each potential share at just 10.4 cents.
AT&T Gains on $10B Buyback, 4.55% Dividend Yield
AT&T shares advanced 0.4% in premarket trading as investors cheered a $10 billion buyback program and a 4.55% dividend yield, with the stock up 10.6% over the past week.
Social Security COLA Seen at 3.8% in 2027, Adding $63B in Benefits
A 3.8% COLA for 2027 would boost Social Security payouts by $63 billion, but taxes and Medicare costs could cut the net benefit.
Wisconsin Tornado: Repair Costs Overshadow Lost Sales for US Stocks
The EF-2 tornado in Wisconsin caused localized damage to WEC Energy, Oshkosh, and Illinois Tool Works. Repair costs are expected to be the primary financial impact, exceeding lost sales.
T-Mobile Restores Network After Outage, Churn Remains Key Risk
T-Mobile US (TMUS) has restored service after a major outage, but analysts highlight ongoing churn risks. Shares edged up 0.8% in premarket trading.
Gossamer Bio Surges on FDA Filing Update; Cash Covenant Looms
Gossamer Bio shares surged 46% on FDA feedback supporting its seralutinib NDA filing. Cash covenant and dilution risks persist.


